Completed OBSERVATIONAL NCT05462314

Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies

An Evaluation of the Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies

Sponsor: Icahn School of Medicine at Mount Sinai

Conditions Biliary Cancer Esophageal Cancer Gastric Cancer Gastrointestinal Cancer Liver Cancer Pancreatic Cancer Rectal Cancer

Updated 5 times since 2022 Last updated: Jan 23, 2025 Started: Mar 29, 2022 Primary completion: Jan 21, 2025 Completion: Jan 21, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Biliary Cancer and Esophageal Cancer, this trial is completed. The trial is conducted by Icahn School of Medicine at Mount Sinai and has accumulated 5 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Feb 2025 — Present [monthly]

Completed

Status: Recruiting → Completed
Sep 2024 — Feb 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Mar 2023 — Jul 2024 [monthly]

Recruiting
Sep 2022 — Mar 2023 [monthly]

Recruiting

First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Icahn School of Medicine at Mount Sinai
Viome

Data source: Viome

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States